0001567619-21-015952.txt : 20210817 0001567619-21-015952.hdr.sgml : 20210817 20210817065017 ACCESSION NUMBER: 0001567619-21-015952 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210812 FILED AS OF DATE: 20210817 DATE AS OF CHANGE: 20210817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Helsel Dave CENTRAL INDEX KEY: 0001543753 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50761 FILM NUMBER: 211180844 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIODYNAMICS INC CENTRAL INDEX KEY: 0001275187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113146460 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 BUSINESS PHONE: 5187981215 MAIL ADDRESS: STREET 1: 14 PLAZA DRIVE CITY: LATHAM STATE: NY ZIP: 12110 4 1 doc1.xml FORM 4 X0306 4 2021-08-12 0 0001275187 ANGIODYNAMICS INC ANGO 0001543753 Helsel Dave 14 PLAZA DRIVE LATHAM NY 12110 0 1 0 0 SVP Global Operations and R&D Common Stock 2021-08-12 4 M 0 2685 0 A 24507 D Common Stock 2021-08-12 4 F 0 788 27.29 D 23719 D Performance Right 2021-08-12 4 M 0 6945 0 D Common Stock 6945 0 D Performance Right Common Stock 8116 8116 D This acquisition of 2,685 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on October 16, 2019. The exempt disposition of 788 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on October 16, 2019. On October 16, 2019, the reporting person received a target grant of 6,945 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 2,395 shares of Common Stock were issued to the reporting person under this grant and the remaining performance share units were forfeited. These securities were previously reported on the Form 4 filed by the reporting person on July 23, 2021. Due to a clerical error, the vesting terms were incorrectly stated in footnote 5 thereof. The correct number of target shares of Common Stock that may be earned includes a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). /s/ Richard C. Rosenzweig, Attorney in Fact 2021-08-16